Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Chimia|August 12, 2020
20 Years of Medicinal Chemistry - Always Look at the Bright Side (of Life)Christoph BossExpert Opinion on Therapeutic Patents|November 20, 2014
Orexin receptor antagonists--a patent review (2010 to August 2014)Christoph BossExpert Opinion on Therapeutic Patents|November 24, 2015
Substituted cyclopentanes, tetrahydrofurans and pyrrolidines as orexin-1-receptor antagonists for treatment of various CNS disorders (WO2015/055994; WO2015/124932; WO2015/124934)Christoph Boss, Catherine RochExpert Opinion on Therapeutic Patents|June 21, 2017
Orexin research: patent news from 2016Christoph Boss, Catherine RochBioorganic & Medicinal Chemistry Letters|June 6, 2015
Recent trends in orexin research--2010 to 2015Christoph Boss, Catherine RochBioorganic & Medicinal Chemistry Letters|June 21, 2016
From bosentan (Tracleer®) to macitentan (Opsumit®): The medicinal chemistry perspectiveChristoph Boss, Martin H Bolli, John GatfieldBioorganic & Medicinal Chemistry Letters|March 6, 2003
Bis-sulfonamides as endothelin receptor antagonistsChristoph Boss, Martin H Bolli, Thomas Weller, et al.Journal of Chemical Information and Modeling|January 19, 2012
Fighting high molecular weight in bioactive molecules with sub-pharmacophore-based virtual screeningModest von Korff, Joel Freyss, Thomas Sander, et al.Bioorganic & Medicinal Chemistry Letters|March 6, 2003
The use of sulfonylamido pyrimidines incorporating an unsaturated side chain as endothelin receptor antagonistsMartin H Bolli, Christoph Boss, Martine Clozel, et al.Pageof 5